Puberty, Precocious
14
3
3
7
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
0.0%
0 terminated out of 14 trials
100.0%
+13.5% vs benchmark
14%
2 trials in Phase 3/4
57%
4 of 7 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 7 completed trials
Clinical Trials (14)
Research of Integrated Traditional Chinese and Western Medicine on Precocious Puberty
Early Breast Growth in Girls Aged 6 to 8 Years in the Current Environmental Context
First Observatory of Precocious Puberty.
Faslodex in McCune-Albright Syndrome
The 3rd COPENHAGEN Puberty Study
Danish Precocious Puberty Study - DAPP Study A National Cohort Study on Incidence and Etiologies for Precocious Puberty
Investigation of the Genetic Causes of Kallmann Syndrome and Reproductive Disorders
The Effect of Decaffeinated Green Tea Polyphenol Intake on the Risk of Precocious Puberty Among Obese Girls
Kisspeptin/GPR54 Pathway and Early Puberty
Effect of a GnRH Injection on Ghrelin Concentrations in Girls With Suspected Premature Puberty
Pediatrics Testotoxicosis Study [Bicalutamide Anastrozole Treatment for Testotoxicosis]
Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty
A Study of Leuprolide 11.25 mg and 30 mg Administered Every 3 Months to Treat Central Precocious Puberty
Study of Lupron Depot In The Treatment of Central Precocious Puberty